- Home
- GPRK vs TECX Comparison
GPRK vs TECX Comparison
Compare GPRK & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- TECX
- Stock Information
- Founded
- GPRK 2002
- TECX 2019
- Country
- GPRK Colombia
- TECX United States
- Employees
- GPRK N/A
- TECX N/A
- Industry
- GPRK Oil & Gas Production
- TECX
- Sector
- GPRK Energy
- TECX
- Exchange
- GPRK Nasdaq
- TECX Nasdaq
- Market Cap
- GPRK 335.7M
- TECX 387.1M
- IPO Year
- GPRK N/A
- TECX 2018
- Fundamental
- Price
- GPRK $6.25
- TECX $15.64
- Analyst Decision
- GPRK Buy
- TECX Buy
- Analyst Count
- GPRK 1
- TECX 6
- Target Price
- GPRK $11.00
- TECX $79.17
- AVG Volume (30 Days)
- GPRK 939.5K
- TECX 513.1K
- Earning Date
- GPRK 11-05-2025
- TECX 11-06-2025
- Dividend Yield
- GPRK 9.36%
- TECX N/A
- EPS Growth
- GPRK N/A
- TECX N/A
- EPS
- GPRK 0.81
- TECX N/A
- Revenue
- GPRK $560,354,000.00
- TECX N/A
- Revenue This Year
- GPRK N/A
- TECX N/A
- Revenue Next Year
- GPRK N/A
- TECX N/A
- P/E Ratio
- GPRK $8.19
- TECX N/A
- Revenue Growth
- GPRK N/A
- TECX N/A
- 52 Week Low
- GPRK $5.66
- TECX $13.70
- 52 Week High
- GPRK $11.72
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- GPRK 45.11
- TECX 34.95
- Support Level
- GPRK $6.18
- TECX $15.92
- Resistance Level
- GPRK $6.77
- TECX $18.61
- Average True Range (ATR)
- GPRK 0.27
- TECX 1.57
- MACD
- GPRK 0.02
- TECX -0.39
- Stochastic Oscillator
- GPRK 26.76
- TECX 7.21
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.